India, Jan. 25 -- Concept Medical Inc, a global developer of drug-delivery technologies for cardiovascular interventions, has announced the successful enrolment of the first patients in the STARS DAPT randomised clinical trial, marking a key milestone in the evaluation of its polymer-free drug-eluting stent, Abluminus np, in patients with ST-segment elevation myocardial infarction (STEMI).

The first four patients were enrolled at the University Hospital of Zurich, Switzerland, by Professor Barbara Stahli and her team, formally initiating the international investigator-led study. The trial will examine different antiplatelet strategies in acute coronary syndrome (ACS) patients undergoing primary percutaneous coronary intervention (PCI). ...